Target intelligence / Profile preview

Macrophage activation via cytokine release

Molecular classification
Other (Biological process), Immune signaling network, Involves multiple classes (receptors, kinases, adaptor proteins, transcription factors)
01

Overview

“Macrophage activation via cytokine release” refers to the complex process wherein macrophages, upon stimulation by pathogens, cytokines, or damage signals, rapidly synthesize and secrete a variety of pro-inflammatory and anti-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-10. These cytokines coordinate the immune response, recruit other immune cells, and influence inflammation, tissue repair, or resolution. The process is central to both protective immunity and the pathogenesis of many diseases. It involves signal transduction through pattern recognition receptors (such as TLRs), cytokine receptors (e.g., IFN-γ receptor), activation of transcription factors (NF-κB, STAT1), and tightly regulated secretion machinery (e.g., SNARE proteins). Dysregulation can result in chronic inflammation or inadequate immune responses. This process encompasses targets but is not itself a canonical molecular target; molecularly, drugs act on specific proteins (often receptors or signaling kinases) that participate in this pathway.

Other names
Macrophage activationCytokine-mediated macrophage activationCytokine secretion by macrophagesMacrophage polarization (M1/M2)
02

Mechanism of action

Inhibition of cytokine synthesis or release (e.g., glucocorticoids) Blockade of cytokine/receptor interactions (e.g., anti-TNF, anti-IL-6) Inhibition of downstream signaling (e.g., JAK inhibitors for IFN-γ/STAT pathway)

03

Biological functions

Immune responseInflammationCytokine productionSignal transductionHost defense
04

Disease associations

InflammationCancerInfectionAutoimmune diseaseCardiovascular disease (atherosclerosis, etc.)Other conditions with immune dysregulation
05

Safety considerations

Broad immunosuppression leading to increased infection riskCytokine release syndrome (if overactivated)Loss of host defenseOff-target effects by global modulation of cytokine pathways
06

Interacting drugs

Glucocorticoids (target overall cytokine production)

4 more in the full profile.

07

Biomarkers

Cytokine levels (TNF-α, IL-1β, IL-6, IL-12, IL-10)Macrophage polarization markers (M1 vs. M2 surface proteins: CD80/CD86 vs. CD163/CD206)Inflammatory gene expression signatures

Beyond the preview

Go deeper on Macrophage activation via cytokine release.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage activation via cytokine release.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call